Biting activity and host attractancy of mosquitoes (Diptera: Culicidae) in Manzhouli, China.

The biting activity and host attractancy of vector mosquitoes are important in assessing the risk of arbovirus transmission, especially where migratory and nonmigrating bird species congregate, such as in Hulun Lake, Manzhouli. In 2009, the population distribution, species diversity, biting activity, and host attractancy of mosquitoes were investigated in Hulan Lake and its associated prairie area. The adult mosquitoes were captured either by human volunteers using aspirators in mosquito nets, by CO2-baited light traps, or by animal-baited traps. In total, 27,004 mosquitoes, representing three genera and 10 species, were collected from Manzhouli, China, in July 2009, of which Aedes dorsalis (Meigen) were most predominant species, followed by Ae. vexans (Meigen). Biting activity peaks by Ae.flavescens (Muller), Ae. dorsalis, and Culex modestus (Facalbi) on human subjects were investigated. Four mosquito species were captured from different animal sheds (sheep, cattle, and goose). Ae. flavescens was more abundant in the cattle shed than in the other two sheds. The Ae. dorsalis in the sheep shed was much higher than in the other animal sheds. The Ae.flavescens collected via chicken-baited traps were significantly higher than those collected via rabbit-baited and pigeon-baited traps. There were no significant differences in the number of Ae. dorsalis and Ae. vexans collected using the three different animal traps.

Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.

BACKGROUND: The long-term immunogenicity after novel vaccine against A(H1N1)pdm09 administration or natural infection has not been well investigated. METHODS: Six cohorts of subjects were followed up for over one year: one-dose A(H1N1)pdm09 vaccine recipient, A(H1N1)pdm09-seasonal trivalent vaccine recipients in different orders, confirmed A(H1N1)pdm09 patients without vaccination, with previous A(H1N1)pdm09 or seasonal influenza vaccination. Peripheral blood mononuclear cells and sera samples were collected at baseline and month 1, 2, 3, 7 and 14 after vaccination (infection). The immunogenicity was determined by hemagglutination-inhibition (HI) and B cell enzyme-linked immunospot (ELISPOT) assays. RESULTS: Single dose of A(H1N1)pdm09 vaccine elicited antibody titer of greater than 1:40 in 40% adults for 1 year and mean live of this adequate antibody was determined as 8.35 months. In contrast, responses after natural infections had lower peaking level and a relatively longer antibody duration, with estimated mean lives of 11.8 months. Pre-vaccination with the seasonal flu vaccine led to a significant reduction in HI titer to A(H1N1)pdm09 one month after vaccination, while pre-vaccination with A(H1N1)pdm09 had no effect on seasonal influenza vaccination. Seasonal flu vaccination followed by A(H1N1)pdm09 infection elicited boosting effect on antibody response against A(H1N1)pdm09. A similar memory B cell response was elicited from both vaccination and infection by ELISPOT assay. CONCLUSIONS: The long-term decay of immunity for A(H1N1)pdm09 vaccine and natural infection indicates the need of revaccination after the host lose protection acquired from either vaccination or infection. Prior infection, rather than the pre-vaccination with seasonal influenza could act on the host immunity to elicit boosting effect on the A(H1N1)pdm09.